Journal
EUROPEAN JOURNAL OF RADIOLOGY
Volume 85, Issue 4, Pages 837-842Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2016.02.006
Keywords
Enhancement fraction; Predicting pCR; Multi-parametric MRI
Funding
- CRUK
- EPSRC
- MRC
- Dept of Health [C1060/A10334, C1060/A16464]
- NHS
- Cancer Research UK [16464] Funding Source: researchfish
Ask authors/readers for more resources
Objective: To prospectively evaluate individual functional MRI metrics for the early prediction of pathological complete response (pCR) to neo-adjuvant chemotherapy (NAC) in breast cancer. Materials and methods: Thirty-two women (median age 52 years; range 32-71 years) with biopsy proven breast cancer due to receive neo-adjuvant anthracycline and/or taxane-based chemotherapy were prospectively recruited following local research ethics committee approval and written informed consent. Breast MRI was performed prior to and after two cycles of NAC and pCR was assessed after surgery. The enhancement fraction (EF), tumour volume, initial area under the gadolinium curve (IAUGC), pharmacokinetic parameters (K-trans, k(ep) and v(e)), the apparent diffusion coefficient (ADC) and R2* values, along with the percentage change in these parameters after two cycles were evaluated according to pCR status using an independent samples t-test. The area under the receiver operating characteristics curve (AUC) was calculated for each parameter. Linear discriminant analysis (LDA) determined the most important parameter in predicting pCR. Results: A reduction in the EF (-41% +/- 38%) and tumour volume (-80% +/- 25%) after 2 cycles of NAC were significantly greater in those achieving pCR (p = 0.025, p = 0.011 respectively). A reduction in the EF of 7% after 2 cycles of NAC identified those more likely to achieve pCR (AUC 0.76). AUC changes in other parameters were tumour volume (0.77), IAUGC (0.64), K-trans (0.60), k(ep) (0.68), v(e) (0.58), ADC (0.69) and R2* (0.41). Conclusion: In a multi-parametric MRI model, the decrease in a non-model based vascular parameter the enhancement fraction as well as the tumour volume are the most important early predictors of pCR in breast cancer. (c) 2016 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available